prof. dr. Loes van Schie

Journal Article
A1
open access

GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery

Loes van Schie (UGent) , Wander Van Breedam (UGent) , Charlotte Roels (UGent) , Bert Schepens (UGent) , Martin Frank, Ahmadreza Mehdipour (UGent) , Bram Laukens, Wim Nerinckx (UGent) , Francis Santens, Simon Devos (UGent) , et al.

(2023) MABS. 15(1).

Add to list

Yeast-produced fructosamine-3-kinase retains mobility after ex vivo intravitreal injection in human and bovine eyes as determined by Fluorescence Correlation Spectroscopy

An-Katrien Minnaert, Loes van Schie (UGent) , Hendrik Grootaert (UGent) , Jonas Himpe (UGent) , Simon Devos (UGent) , Wannes Weyts (UGent) , Herlinde De Keersmaecker (UGent) , Kevin Braeckmans (UGent) , Elisabeth Van Aken (UGent) , Joris Delanghe (UGent) , et al.

(2022) INTERNATIONAL JOURNAL OF PHARMACEUTICS. 621.

Add to list

Miscellaneous

GlycoVHH : introducing N-glycans on the camelid VHH antibody scaffold : optimal sites and use for macrophage delivery

Loes van Schie (UGent) , Wander Van Breedam (UGent) , Charlotte Roels (UGent) , Bert Schepens (UGent) , Martin Frank, Ahmadreza Mehdipour (UGent) , Bram Laukens, Wim Nerinckx (UGent) , Francis Santens, Simon Devos (UGent) , et al.

(2022) BioRXiv.

Add to list

Journal Article
A1
open access

Exploration of synergistic action of cell wall-degrading enzymes against mycobacterium tuberculosis

Loes van Schie (UGent) , Katlyn Borgers, Gitte Michielsen (UGent) , Evelyn Plets (UGent) , Marnik Vuylsteke, Petra Tiels (UGent) , Nele Festjens (UGent) and Nico Callewaert (UGent)

(2021) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 65(10).

Add to list

Journal Article
A1
open access

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models

Bert Schepens (UGent) , Loes van Schie (UGent) , Wim Nerinckx (UGent) , Kenny Roose (UGent) , Wander Van Breedam (UGent) , Daria Fijalkowska (UGent) , Simon Devos (UGent) , Wannes Weyts (UGent) , Sieglinde De Cae (UGent) , Sandrine Vanmarcke (UGent) , et al.

(2021) SCIENCE TRANSLATIONAL MEDICINE. 13(621).

Add to list

Journal Article
A1
open access

A potential role for fructosamine-3-kinase in cataract treatment

Sander De Bruyne, Loes van Schie (UGent) , Jonas Himpe (UGent) , Filip De Somer (UGent) , Inge Everaert (UGent) , Wim Derave (UGent) , Caroline Van den Broecke (UGent) , Manon Huizing, Nezahat Bostan, Marijn Speeckaert (UGent) , et al.

(2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 22(8).

Add to list

Journal Article
A1
open access

Development of a counterselectable transposon to create markerless knockouts from an 18,432-clone ordered Mycobacterium bovis bacillus Calmette-Guérin mutant resource

Katlyn Borgers, Kristof Vandewalle, Annelies Van Hecke (UGent) , Gitte Michielsen (UGent) , Evelyn Plets (UGent) , Loes van Schie (UGent) , Sandrine Vanmarcke (UGent) , Laurent Schindfessel (UGent) , Nele Festjens (UGent) and Nico Callewaert (UGent)

(2020) MSYSTEMS. 5(4).

Add to list

Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies

Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam (UGent) , Kenny Roose (UGent) , Loes van Schie (UGent) , Markus Hoffmann, Stefan Poehlmann, et al.

(2020) CELL. 181(5). p.1004-1015

Add to list

Miscellaneous

Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies (vol 181, pg 1004, 2020)

Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam (UGent) , Kenny Roose (UGent) , Loes van Schie (UGent) , Markus Hoffmann, Stefan Pohlmann, et al.

(2020) CELL. 181(6). p.1436-1441

Add to list

PhD Thesis

Exploring protein therapeutics to fight tuberculosis

Loes van Schie (UGent)

(2019)

Academic Bibliography

prof. dr. Loes van Schie

GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery

Yeast-produced fructosamine-3-kinase retains mobility after ex vivo intravitreal injection in human and bovine eyes as determined by Fluorescence Correlation Spectroscopy

GlycoVHH : introducing N-glycans on the camelid VHH antibody scaffold : optimal sites and use for macrophage delivery

Exploration of synergistic action of cell wall-degrading enzymes against mycobacterium tuberculosis

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models

A potential role for fructosamine-3-kinase in cataract treatment

Development of a counterselectable transposon to create markerless knockouts from an 18,432-clone ordered Mycobacterium bovis bacillus Calmette-Guérin mutant resource

Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies

Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies (vol 181, pg 1004, 2020)

Exploring protein therapeutics to fight tuberculosis

Contents

Support

Contact